Form 4 · Filed Apr 17, 2026, 12:00 PM UTC
LIXT/LIXTE BIOTECHNOLOGY HOLDINGS, INC.
Felix Lourdes — director
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
2 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Apr 15, 2026 | A | other | 25,000 | — | — | 25,000 |
| Apr 15, 2026 | D | other | 25,000 | — | — | 0 |
Source: SEC EDGAR raw filing ↗ · Accession 0001493152-26-017852